Chenyi Huang

Chenyi Huang

Auto-generated profile, based on publicly available information

Chenyi Huang

School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
CLChuchu Lin
Chuchu Lin
CHChenyi Huang
Chenyi Huang
ZSZhaoqing Shi
Zhaoqing Shi
MOMeitong Ou
Meitong Ou
SSShengjie Sun
Shengjie Sun
Lin MeiLin Mei
Lin Mei
Hydrogen sulfide (H2S) is the most recently discovered gasotransmitter molecule that activates multiple intracellular signaling pathways and exerts concentration-dependent antitumor effect by interfering with mitochondrial respiration and inhibiting cellular ATP generation. Inspired by the fact that H2S can also serve as a promoter for intracellular Ca2+ influx, tumor-specific nanomodulators (I-CaS@PP) have been constructed by encapsulating calcium sulfide (CaS) and indocyanine green (ICG) into methoxy poly (ethylene glycol)-b-poly (lactide-co-glycolide) (PLGA-PEG). I-CaS@PP can achieve tumor-specific biodegradability with high biocompatibility and pH-responsive H2S release. The released H2S can effectively suppress the catalase (CAT) activity and synergize with released Ca2+ to facilitate abnormal Ca2+ retention in cells, thus leading to mitochondria destruction and amplification of oxidative stress. Mitochondrial dysfunction further contributes to blocking ATP synthesis and downregulating heat shock proteins (HSPs) expression, which is beneficial to overcome the heat endurance of tumor cells and strengthen ICG-induced photothermal performance. Such a H2S-boosted Ca2+-involved tumor-specific therapy exhibits highly effective tumor inhibition effect with almost complete elimination within 14-day treatment, indicating the great prospect of CaS-based nanomodulators as antitumor therapeutics.

14 May 2022 in Chinese Chemical Letters
Verified
Journal Article
Closed access
TWTianqi Wang
Tianqi Wang
YFYanan Fu
Yanan Fu
SSShengjie Sun
Shengjie Sun
CHChenyi Huang
Chenyi Huang
YYYunfei Yi
Yunfei Yi
MWMeiying Wu
Meiying Wu

10 June 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
CHChenyi Huang
Chenyi Huang
JTJia Tang
Jia Tang
YLYuanqi Liu
Yuanqi Liu
TCTing Chen
Ting Chen
JQJunyang Qi
Junyang Qi
MWMeiying Wu
Meiying Wu

1 January 2021 in Research
Verified
Journal Article
Open access
PDF file
YZYun Zhou
Yun Zhou
MYMian Yu
Mian Yu
CTChangjun Tie
Changjun Tie
YDYang Deng
Yang Deng
Junqing WangJunqing Wang
Junqing Wang
MWMeiying Wu
Meiying Wu
Benefiting from treating diseases at the genetic level, gene therapy has been considered a new revolution in the biomedical field. However, the extracellular and intracellular barriers during gene transport such as enzymatic degradation and endo-/lysosomal sequestration significantly compromise the therapeutic efficacy. Though photochemical internalization (PCI) has emerged as a promising approach for causing endo-/lysosomal leakage with translocation of the internalized molecules into the cytosol, its effect is still unsatisfactory due to the insufficient light penetration depth. Here, we develop tumor microenvironment-specific enhanced gene delivery by means of ROS generated from the in situ cascaded catalytic reactions in tumors involving GOx-mediated redox reaction and Mn 2+ -mediated Fenton-like reaction. The efficient enzymatic protection and successful endo-/lysosomal escape of cargo gene complexes have been demonstrated. Moreover, anti-Twist siRNA-loaded G@MMSNs-P exhibit tumor-specific biodegradation, excellent T 1 -weighted MR imaging, and significant inhibitory effects against breast cancer growth and pulmonary metastasis.